FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3039139035> ?p ?o ?g. }

• W3039139035 endingPage "1832" @default.
• W3039139035 startingPage "1828" @default.
• W3039139035 abstract "There have been several efforts to predict mortality after autologous stem cell transplantation (ASCT), such as the hematopoietic cell transplant-comorbidity index (HCT-CI), described for allogeneic stem cell transplantation and validated for ASCT, but there is no composite score in the setting of ASCT combining comorbidities with other clinical characteristics. Our aim is to describe a comprehensive score combining comorbidities with other clinical factors and to analyze the impact of this score on nonrelapse mortality (NRM), overall survival (OS), and early morbidity endpoints (mechanical ventilation, shock or dialysis) after ASCT. For the training cohort, we retrospectively reviewed data of 2068 adult patients who received an ASCT in Argentina (October 2002 to June 2017) for multiple myeloma or lymphoma. For the validation cohort, we analyzed 2168 ASCTs performed in the Medical College of Wisconsin and Spanish stem cell transplant group (Grupo Español de Trasplante Hematopoyético (GETH)) (January 2012 to December 2018). We first performed a multivariate analysis for NRM in order to select and assign weight to the risk factors included in the score (male patients, aged 55 to 64 and ≥65 years, HCT-CI ≥3, Hodgkin lymphoma and non-Hodgkin lymphoma). The hazard ratio for NRM increased proportionally with the score. Patients were grouped as low risk (LR) with a score of 0 to 1 (686, 33%), intermediate risk (IR) with a score of 2 to 3 (1109, 53%), high risk (HR) with a score of 4 (198, 10%), and very high risk (VHR) with a score of ≥5 (75, 4%). The score was associated with a progressive increase in all the early morbidity endpoints. Moreover, the score was significantly associated with early NRM (day 100: 1.5% versus 2.4% versus 7.6% versus 17.6%) as well as long term (1 to 3 years; 1.8% to 2.3% versus 3.8% to 4.9% versus 11.7% to 14.5% versus 25.0% to 27.4%, respectively; P< .0001) and OS (1 to 5 years; 94% to 73% versus 89% to 75% versus 76% to 47% versus 65% to 52% respectively; P < .0001). The score was validated in an independent cohort (N = 2168) and was significantly associated with early and late events. In conclusion, we developed and validated a novel score predicting NRM and OS in 2 large cohorts of more than 2000 autologous transplant patients. This tool can be useful for tailoring conditioning regimens or defining risk for transplant program decision making." @default.
• W3039139035 created "2020-07-10" @default.
• W3039139035 creator A5001461459 @default.
• W3039139035 creator A5002364548 @default.
• W3039139035 creator A5005772211 @default.
• W3039139035 creator A5007551071 @default.
• W3039139035 creator A5009263584 @default.
• W3039139035 creator A5014360320 @default.
• W3039139035 creator A5019763289 @default.
• W3039139035 creator A5022020148 @default.
• W3039139035 creator A5027810888 @default.
• W3039139035 creator A5028564534 @default.
• W3039139035 creator A5030291732 @default.
• W3039139035 creator A5032478325 @default.
• W3039139035 creator A5035799376 @default.
• W3039139035 creator A5042450014 @default.
• W3039139035 creator A5043632370 @default.
• W3039139035 creator A5050962556 @default.
• W3039139035 creator A5055531792 @default.
• W3039139035 creator A5064228344 @default.
• W3039139035 creator A5069402657 @default.
• W3039139035 creator A5074011968 @default.
• W3039139035 creator A5075722788 @default.
• W3039139035 creator A5076935487 @default.
• W3039139035 creator A5076977373 @default.
• W3039139035 creator A5079695985 @default.
• W3039139035 creator A5090375120 @default.
• W3039139035 date "2020-10-01" @default.
• W3039139035 modified "2023-10-17" @default.
• W3039139035 title "Predicting Mortality after Autologous Transplant: Development of a Novel Risk Score" @default.
• W3039139035 cites W1076230489 @default.
• W3039139035 cites W1511201911 @default.
• W3039139035 cites W1597967005 @default.
• W3039139035 cites W1755350398 @default.
• W3039139035 cites W1954992673 @default.
• W3039139035 cites W1967234361 @default.
• W3039139035 cites W1974696923 @default.
• W3039139035 cites W1979533218 @default.
• W3039139035 cites W1990872914 @default.
• W3039139035 cites W2017706891 @default.
• W3039139035 cites W2036486519 @default.
• W3039139035 cites W2041944188 @default.
• W3039139035 cites W2067831127 @default.
• W3039139035 cites W2075666986 @default.
• W3039139035 cites W2080472475 @default.
• W3039139035 cites W2106878200 @default.
• W3039139035 cites W2116299683 @default.
• W3039139035 cites W2118315123 @default.
• W3039139035 cites W2128812336 @default.
• W3039139035 cites W2137040543 @default.
• W3039139035 cites W2145233309 @default.
• W3039139035 cites W2162309072 @default.
• W3039139035 cites W2163208523 @default.
• W3039139035 cites W2285589106 @default.
• W3039139035 cites W2413892643 @default.
• W3039139035 cites W2438094103 @default.
• W3039139035 cites W2534677658 @default.
• W3039139035 cites W2592540477 @default.
• W3039139035 cites W2731092161 @default.
• W3039139035 cites W2935210822 @default.
• W3039139035 doi "https://doi.org/10.1016/j.bbmt.2020.06.028" @default.
• W3039139035 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32640312" @default.
• W3039139035 hasPublicationYear "2020" @default.
• W3039139035 type Work @default.
• W3039139035 sameAs 3039139035 @default.
• W3039139035 citedByCount "6" @default.
• W3039139035 countsByYear W30391390352021 @default.
• W3039139035 countsByYear W30391390352022 @default.
• W3039139035 countsByYear W30391390352023 @default.
• W3039139035 crossrefType "journal-article" @default.
• W3039139035 hasAuthorship W3039139035A5001461459 @default.
• W3039139035 hasAuthorship W3039139035A5002364548 @default.
• W3039139035 hasAuthorship W3039139035A5005772211 @default.
• W3039139035 hasAuthorship W3039139035A5007551071 @default.
• W3039139035 hasAuthorship W3039139035A5009263584 @default.
• W3039139035 hasAuthorship W3039139035A5014360320 @default.
• W3039139035 hasAuthorship W3039139035A5019763289 @default.
• W3039139035 hasAuthorship W3039139035A5022020148 @default.
• W3039139035 hasAuthorship W3039139035A5027810888 @default.
• W3039139035 hasAuthorship W3039139035A5028564534 @default.
• W3039139035 hasAuthorship W3039139035A5030291732 @default.
• W3039139035 hasAuthorship W3039139035A5032478325 @default.
• W3039139035 hasAuthorship W3039139035A5035799376 @default.
• W3039139035 hasAuthorship W3039139035A5042450014 @default.
• W3039139035 hasAuthorship W3039139035A5043632370 @default.
• W3039139035 hasAuthorship W3039139035A5050962556 @default.
• W3039139035 hasAuthorship W3039139035A5055531792 @default.
• W3039139035 hasAuthorship W3039139035A5064228344 @default.
• W3039139035 hasAuthorship W3039139035A5069402657 @default.
• W3039139035 hasAuthorship W3039139035A5074011968 @default.
• W3039139035 hasAuthorship W3039139035A5075722788 @default.
• W3039139035 hasAuthorship W3039139035A5076935487 @default.
• W3039139035 hasAuthorship W3039139035A5076977373 @default.
• W3039139035 hasAuthorship W3039139035A5079695985 @default.
• W3039139035 hasAuthorship W3039139035A5090375120 @default.
• W3039139035 hasBestOaLocation W30391390351 @default.
• W3039139035 hasConcept C11783203 @default.
• W3039139035 hasConcept C126322002 @default.

• next